Applications of Metallic Nanoparticles in the Skin Cancer Treatment

• Published in: BioMed research international Vol. 2022; pp. 2346941 - 20
• Main Authors: Marzi, Mahrokh, Osanloo, Mahmoud, Vakil, Mohammad Kazem, Mansoori, Yaser, Ghasemian, Abdolmajid, Dehghan, Azizallah, Zarenezhad, Elham
• Format: Journal Article
• Language: English
• Published: United States Hindawi 14-11-2022; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Administration, Cutaneous; Antimitotic agents; Antineoplastic agents; Antineoplastic drugs; Antitumor agents; Bioaccumulation; Bioavailability; Biocompatibility; Biodegradability; Biodegradation; Cancer therapies; Chemical properties; Chemotherapy; Controlled release; Drug carriers; Drug Carriers - chemistry; Drug delivery; Drug delivery systems; Drug Delivery Systems - methods; Drug metabolism; Drug therapy; Electromagnetic radiation; Electrostatic charge; Health aspects; Humans; Hyperthermia; In vivo methods and tests; Innovations; Lipids; Magnetic resonance imaging; Magnetite Nanoparticles - chemistry; Medicine; Melanoma; Multidrug resistance; Nanoparticles; Nanotechnology; Pharmacokinetics; Review; Side effects; Skin cancer; Skin Neoplasms - drug therapy; Toxicity; Tumors; Iran; United States > US
• ISSN: 2314-6133; 2314-6141; 2314-6141
• DOI: 10.1155/2022/2346941

Skin cancer is one of leading cancers globally, divided into two major categories including melanoma and nonmelanoma. Skin cancer is a global concern with an increasing trend, hence novel therapies are essential. The local treatment strategies play a key role in skin cancer therapy. Nanoparticles (NPs) exert potential applications in medicine with huge advantages and have the ability to overcome common chemotherapy problems. Recently, NPs have been used in nanomedicine as promising drug delivery systems. They can enhance the solubility of poorly water-soluble drugs, improve pharmacokinetic properties, modify bioavailability, and reduce drug metabolism. The high-efficient, nontoxic, low-cost, and specific cancer therapy is a promising goal, which can be achieved by the development of nanotechnology. Metallic NPs (MNPs) can act as important platforms. MNPs development seeks to enhance the therapeutic efficiency of medicines through site specificity, prevention of multidrug resistance, and effective delivery of therapeutic factors. MNPs are used as potential arms in the case of cancer recognition, such as Magnetic Resonance Imaging (MRI) and colloidal mediators for magnetic hyperthermia of cancer. The applications of MNPs in the cancer treatment studies are mostly due to their potential to carry a large dose of drug, resulting in a high concentration of anticancer drugs at the target site. Therefore, off-target toxicity and suffering side effects caused by high concentration of the drug in other parts of the body are avoided. MNPs have been applied as drug carriers for the of improvement of skin cancer treatment and drug delivery. The development of MNPs improves the results of many cancer treatments. Different types of NPs, such as inorganic and organic NPs have been investigated in vitro and in vivo for the skin cancer therapy. MNPs advantages mostly include biodegradability, electrostatic charge, good biocompatibility, high drug payload, and low toxicity. However, the use of controlled-release systems stimulated by electromagnetic waves, temperature, pH, and light improves the accumulation in tumor tissues and improves therapeutic outcomes. This study (2019-2022) is aimed at reviewing applications of MNPs in the skin cancer therapy.